Category Archives: – NEJM

Osimertinib in Untreated EGFR-Mutated Advanced Non-Small-Cell Lung Cancer (FLAURA)

November 20, 2017- Interviewed by Steven E. Greer, MD We interviewed Emory University oncologist Suresh S. Ramalingam, M.D. about his NEJM

Posted in - NEJM, Cardiac surgery, Emory, Oncology | Leave a comment

CT-scan screening for heart disease fails to show benefit

March 23, 2015- Interviewed by Steven E. Greer, MD We interviewed the Principal Investigator of the PROMISE trial, Pamela Douglas, MD from Duke.

Posted in - NEJM, - Policy, Cardiology, CMS, Duke, Radiology | Leave a comment

Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis

May 23, 2017- interviewed by Steven E. Greer, MD We interviewed polumonologist Michael Wechsler, MD about his paper in the NEJM testing mepolizumab

Posted in - NEJM, National Jewish Health, Pulmonology, Rheumatology | Leave a comment

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors

January 12, 2017- Interviewed by Steven E. Greer, MD Jonathan Strosberg, MD of

Posted in - NEJM, Oncology | Leave a comment

The bionic pancreas data

July 2, 2014- Interviewed by Steven E. Greer, MD The New England Journal of Medicine recently published the early clinical data on the “bionic pancreas”

Posted in - Medical Devices, - NEJM, Boston University, Diabetes and endocrinology | Leave a comment

Aerobic or Resistance Exercise, or Both, in Dieting Obese Older Adults

June 14, 2017- Interviewed by Steven E. Greer, MD We interviewed Dennis Villareal, MD, the author of the NEJM paper “Aerobic or Resistance

Posted in - NEJM, Bariatric surgery, Baylor, Diabetes and endocrinology, Geriatrics, Internal Medicine | Leave a comment

The ACA’s THC program: A pilot program to fund residency training outside of the traditional hospital setting

September 6, 2016- Interviewed by Steven E. Greer, MD

Posted in - NEJM, - Policy, CMS, George Washington Univ | Leave a comment

Ibrance (palbociclib) to treat advanced breast cancer

November 28, 2016- Interviewed by Steven E. Greer, MD We interviewed Richard Finn,

Posted in - Biotech, - NEJM, - Pharma, Oncology, UCLA | Leave a comment

10-year follow-up on the CREST carotid stenting trial

March 4, 2016- Interviewed by Steven E. Greer, MD The 10-year follow-up data on the CREST carotid stenting vs. CEA trail were published

Posted in - Medical Devices, - NEJM, Cardiac surgery, Cardiology, Neurology, Neurosurgery, Vascular Surgery | Leave a comment

A second blow to Atul Gawande (and Obamacare)

December 15, 2015- by Steven E. Greer, MD Atul Gawande, MD, a surgeon working at one of the Harvard affiliated hospitals, wrote an influential essay in the

Posted in - NEJM, - Opinion, CMS, Congress, Harvard | Leave a comment

The telomerase inhibitor Imetelstat developed by Geron

September 9, 2015-

Posted in - Biotech, - NEJM, Oncology | Leave a comment

Are the new PCSK9 cholesterol lowering drugs worth the high cost?

December 16, 2015- Interviewed by Steven E. Greer, MD

Posted in - Biotech, - NEJM, - Opinion, - Pharma, - Policy, Cardiology, CMS, FDA | Leave a comment

The NEJM editorial board blew it on anti-quarantine Ebola essay

October 28, 2014- By Steven E. Greer, MD Jeffrey Drazen and the other editors of the New England Journal of Medicine rushed out an opinion

Posted in - NEJM, - Opinion, - Policy, Infectious disease | Leave a comment

Cutting through the hype surrounding gluten

October 19, 2014- Interviewed by Steven E. Greer, MD Did you know that one out of three Americans think that they are “gluten intolerant”. Of those 100

Posted in - NEJM, - Policy, Gastroenterology and liver, Pediatrics | Leave a comment

Long-term contraception is effective and underutilized

October 1, 2014- Interviewed by Steven E. Greer Jeffrey F. Peipert, M.D., Ph.D. of Washington university discusses his original article in the NEJM

Posted in - NEJM, Obstetrics and Gynecology, Washington University | Leave a comment

Single-pill combo regimens for HIV

July 28, 2014- Interviewed by Steven E. Greer, MD Rajesh Tim Gandhi, MD of the Massachusetts General Hospital discusses the NEJM review paper

Posted in - NEJM, Harvard, Infectious disease | Leave a comment

Jay Skyler discusses the recent bionic pancreas data

June 22, 2014- By Steven E. Greer, MD This week, the mainstream press reported on the “bionic pancreas” data published in the NEJM

Posted in - Medical Devices, - NEJM, Diabetes and endocrinology | Leave a comment

The Massachusetts General trauma response to the Boston bombings

May 3, 2013- Interviewed by Steven E. Greer, MD Paul Biddinger, MD, Medical Director for Emergency Preparedness, Massachusetts General

Posted in - NEJM, - Policy, Trauma Surgery | Leave a comment

Review of the CREST trial of carotid stenting

The CREST trial, published earlier this year, was the latest large-scale, randomized, controlled

Posted in - Medical Devices, - NEJM, Cardiac surgery, Cardiology, Mayo Clinic, Neurosurgery | Leave a comment

Steven Cummings, MD: The denosumab FREEDOM trial

August 11, 2009- Dr. Steven Cummings, director of the San Francisco Coordinating Center and faculty of UCSF, and

Posted in - Biotech, - NEJM, - Pharma, Diabetes and endocrinology, Obstetrics and Gynecology, Orthopedic surgery, Primary care medicine, Radiology, Spine surgery, Sports medicine, UC San Francisco | Leave a comment